Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617001120369
Ethics application status
Approved
Date submitted
1/06/2017
Date registered
31/07/2017
Date last updated
31/07/2017
Type of registration
Retrospectively registered
Titles & IDs
Public title
Effects of Single dose Dexmedetomidine on recovery profile in ambulatory surgery
Query!
Scientific title
Effect of single-dose dexmedetomidine on postoperative recovery after ambulatory ureteroscopy and ureteric stenting: a double blind randomized controlled study
Query!
Secondary ID [1]
292073
0
Nil
Query!
Universal Trial Number (UTN)
U1111-1197-3249
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
post operative pain
303487
0
Query!
Condition category
Condition code
Anaesthesiology
302903
302903
0
0
Query!
Anaesthetics
Query!
Anaesthesiology
302904
302904
0
0
Query!
Pain management
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Sixty patients were randomised to receive IV dexmedetomidine 0.5 mcg.kg-1 (Group DEX, n=30) or IV 0.9% saline (Group P, n=30) as intravenous infusion over 20 minutes at pre induction of anaesthesia .
Query!
Intervention code [1]
298213
0
Treatment: Drugs
Query!
Comparator / control treatment
The control group received intra venous saline 20 mls.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
302291
0
To assess the effect of Dexmedetomidine on the patient's minimum alveolar concentration (MAC). The MAC of the patient is monitored using a tool already incorporated in the general anaesthesia machine.
Query!
Assessment method [1]
302291
0
Query!
Timepoint [1]
302291
0
every 5 minutes intraoperatively
Query!
Secondary outcome [1]
335394
0
To assess postoperative pain scores using a pain assessment scale ie the visual analogue score which is widely used in many hospital around the world.
Query!
Assessment method [1]
335394
0
Query!
Timepoint [1]
335394
0
From immediately post operation and every 12 hours for 3 days post operative.
Query!
Eligibility
Key inclusion criteria
All patients of American Society Anaesthesiologists physical status I-II, aged between 18-65 years who underwent elective ureteroscopy and ureteric stenting in our ambulatory day care centre.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
All patients with increased serum creatinine (> 200µmolL-1), advanced liver disease (liver enzymes twice the normal range or higher), those with a history of chronic use of sedatives/ narcotics or analgesics, known alcohol or drug abuse, allergy to study medication and those devoid of postoperative telephone access.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
sealed opaque envelopes that concealed group allocation.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
using a computer generated random number table in blocks of ten.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
The sample size was based on our primary outcome measure of anaesthetic minimum alveolar concentration (MAC). From an initial pilot study involving 16 patients, we found the mean (SD) MAC of Sevoflurane to be 0.85 (0.19). We deemed a MAC reduction of 0.25 to be a clinically significant difference between the two groups. Prospective power analysis indicated that with a = 0.05 and power of 80%, 25 patients per group were needed. Therefore we recruited 30 patients per group to account for dropouts. Parametric data and non-parametric data was analysed with Student’s t test and Mann-Whitney U-test respectively, and Fisher’s exact test was used to compare side effects using SPSS 15.0 TM (SPSS Inc., Chicago, IL, USA) software. A p value of < 0.05 was deemed statistically significant.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
21/10/2008
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
27/04/2010
Query!
Date of last data collection
Anticipated
Query!
Actual
2/05/2010
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
60
Query!
Recruitment outside Australia
Country [1]
8931
0
Malaysia
Query!
State/province [1]
8931
0
Kuala Lumpur
Query!
Funding & Sponsors
Funding source category [1]
296599
0
University
Query!
Name [1]
296599
0
university Malaya
Query!
Address [1]
296599
0
Dept of Anaesthesiology,
Faculty of Medicine,
Jalan Lembah Pantai,
50603 Kulala Lumpur,
Malaysia
Query!
Country [1]
296599
0
Malaysia
Query!
Primary sponsor type
University
Query!
Name
University Malaya
Query!
Address
Dept of Anaesthesiology,
Faculty of Medicine,
Jalan Lembah Pantai,
50603 Kulala Lumpur,
Malaysia
Query!
Country
Malaysia
Query!
Secondary sponsor category [1]
295563
0
None
Query!
Name [1]
295563
0
Query!
Address [1]
295563
0
Query!
Country [1]
295563
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
297826
0
Universiti Malaya Medical centre Ethics committee
Query!
Ethics committee address [1]
297826
0
Jln Lembah Pantai, 50603 Kuala Lumpur
Query!
Ethics committee country [1]
297826
0
Malaysia
Query!
Date submitted for ethics approval [1]
297826
0
30/07/2008
Query!
Approval date [1]
297826
0
27/08/2008
Query!
Ethics approval number [1]
297826
0
672.7
Query!
Summary
Brief summary
We evaluated the effect of a single pre-induction dose of dexmedetomidine on anaesthetic requirements, postoperative pain and clinical recovery after ambulatory ureteroscopy and ureteric stenting under general anaesthesia. Sixty patients were randomised to receive IV dexmedetomidine 0.5 mcg.kg-1 (Group DEX, n=30) or IV saline (Group P, n=30) maintained with Sevoflurane: oxygen: air, titrated to BIS 40-60. Pain intensity, sedation, rescue analgesics, nausea/vomiting and resumption of daily activities were recorded at 1 hour, and postoperative day (POD) 1-5. Group DEX patients had significant reduction in sevoflurane minimum alveolar concentration (MAC), mean (SD) DEX vs. Placebo 0.6 (0.2) vs. 0.9 (0.1), p = 0.037; reduced postoperative resting pain at 1hr (VAS 0-10) (mean (SD) 1.00 (1.84) vs. 2.63 (2.78), p = 0.004), POD 1 (mean (SD) 1.50 (1.48) vs. 2.87 (2.72), p = 0.002), POD 2 (0.53 (0.97) vs. 1.73 (1.96), p = 0.001) and POD 3 (0.30 (0.75) vs. 0.89 (1.49), p = 0.001). DEX patients also had less pain on movement POD 1 (3.00 (2.12) vs. 4.30 (3.10), p = 0.043) and POD 2 (2.10 (1.98) vs. 3.10 (2.46), p = 0.040), with higher resumption of daily activities by 48 hours compared to placebo, 87% vs. 63%, p = 0.04. We conclude that a single dose of dexmedetomidine was a useful adjuvant in reducing MAC and postoperative pain (at 1hr and POD 1-3), facilitating faster return to daily activities by 48hr.
Query!
Trial website
Query!
Trial related presentations / publications
none
Query!
Public notes
Query!
Contacts
Principal investigator
Name
75202
0
A/Prof Ina Ismiarti Shariffuddin
Query!
Address
75202
0
Dept of Anaesthesiology,
Faculty of Medicine,
Jln Lembah Pantai,
50603 Kuala Lumpur,
Malaysia
Query!
Country
75202
0
Malaysia
Query!
Phone
75202
0
+60379492052
Query!
Fax
75202
0
+60379556705
Query!
Email
75202
0
[email protected]
Query!
Contact person for public queries
Name
75203
0
Ina Ismiarti Shariffuddin
Query!
Address
75203
0
Dept of Anaesthesiology,
Faculty of Medicine,
Jln Lembah Pantai,
50603 Kuala Lumpur,
Malaysia
Query!
Country
75203
0
Malaysia
Query!
Phone
75203
0
+60379492052
Query!
Fax
75203
0
+60379556705
Query!
Email
75203
0
[email protected]
Query!
Contact person for scientific queries
Name
75204
0
Ina Ismiarti Shariffuddin
Query!
Address
75204
0
Dept of Anaesthesiology,
Faculty of Medicine,
Jln Lembah Pantai,
50603 Kuala Lumpur,
Malaysia
Query!
Country
75204
0
Malaysia
Query!
Phone
75204
0
+60379492052
Query!
Fax
75204
0
+60379556705
Query!
Email
75204
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Effect of single-dose dexmedetomidine on postoperative recovery after ambulatory ureteroscopy and ureteric stenting: A double blind randomized controlled study.
2018
https://dx.doi.org/10.1186/s12871-017-0464-6
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF